Form 4: UVE Officer Ropiecki Granted 3,500 Restricted Stock Units

Sentiment:

Insider Transaction Report


Universal Insurance Holdings' Principal Accounting Officer, Gary Ropiecki, was granted 3,500 restricted stock units vesting over three years.

Summary

  • Gary Lloyd Ropiecki, Principal Accounting Officer of Universal Insurance Holdings, Inc. (UVE), acquired 3,500 Restricted Stock Units (RSUs).
  • The grant date for these RSUs was December 5, 2025.
  • Each RSU represents a contingent right to receive one share of UVE common stock.
  • The RSUs will vest in three approximately equal installments on the first, second, and third anniversaries of the grant date, contingent on Ropiecki's continued employment.

Sentiment

Score: 7

Explanation: The grant of RSUs to a key officer is generally a positive sign for retention and alignment of interests, though it's a routine compensation event rather than a major strategic announcement.

Positives

  • The grant of 3,500 Restricted Stock Units to a key officer aligns management's interests with long-term shareholder value.
  • The vesting schedule over three years encourages retention of the Principal Accounting Officer.

Negatives

  • No immediate cash compensation or direct stock purchase, as these are restricted units with a future vesting schedule.

Risks

  • The vesting of the restricted stock units is subject to the reporting person's continued employment through the applicable vesting dates.

Future Outlook

The grant of restricted stock units with a multi-year vesting schedule indicates a long-term incentive for the Principal Accounting Officer, aligning future performance with shareholder interests.

Industry Context

This is a standard executive compensation practice in publicly traded companies, particularly in the insurance sector, to incentivize long-term performance and retention of key personnel.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) as a form of executive compensation is a common practice across various industries, including insurance, aligning executive incentives with long-term company performance.
  • The three-year vesting schedule is typical for such grants, comparable to practices at peers like Travelers (TRV) or Allstate (ALL) for similar executive roles, promoting retention and sustained performance.

Related Party Transactions

  • Grant of 3,500 Restricted Stock Units to Gary Lloyd Ropiecki, Principal Accounting Officer.

Stakeholder Impact

  • Shareholders: The grant aligns the Principal Accounting Officer's interests with long-term shareholder value creation, as the value of the RSUs is tied to the company's stock performance.
  • Employees: Demonstrates the company's use of equity-based compensation to incentivize and retain key talent.

Next Steps

  • The restricted stock units will vest in three approximately equal installments on December 5, 2026, December 5, 2027, and December 5, 2028, subject to continued employment.

Key Dates

DateDescription
12/05/2025Grant date of 3,500 Restricted Stock Units to Gary Ropiecki.
12/09/2025Date Form 4 was signed by Gary Ropiecki.

Recommendation

hold

This Form 4 reports a routine grant of restricted stock units to a key executive as part of their compensation package. While it aligns management's interests with shareholders, it does not provide new fundamental information that would warrant a change in investment recommendation. It's a standard insider transaction.

Keywords

Universal Insurance Holdings, UVE, Restricted Stock Units, RSU, Insider Trading, Form 4, Executive Compensation, Gary Ropiecki, Stock Grant, Officer Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.